Scientific Board
Process Analytical Technology is one of the most exciting and important advanced technology areas meeting both the current challenges, as well as the future needs of industry. Since 1987, the IFPAC conferences have generated the enthusiastic response that resulted in the creation of a series of International meetings featuring the regulators, manufacturers, researchers and industry users. Equipment and services are typically on display during our events.
So please join us...meet with your colleagues...the people who are the foundation of Process Analytical Technology (PAT), QbD, Process Understanding & Control, and Real-Time Analytics. Come share in discussions, give input and get ideas for the future well-being of the industry.
IFPAC - 2024 SCIENTIFIC BOARD
Co-Chairs
Jun Huang, Regeneron, Tarrytown, NY
Geng (Michael) Tian, FDA, CDER, OPQ, OTR, Silver Spring, MD
Charles E. (Chuck) Miller, Aspen Technology, Lansdale, PA
Members
Christian Airiau, Sanofi, Framingham, MA
Ahmad Almaya, Eli Lilly, Indianapolis, IN
Scott Armstrong, Phillips 66, Houston, TX
Bob Bear, Ametek, Pittsburgh, PA
Tara Gooen Bizjak, FDA, CDER, OC, OMQ, MGPS, Silver Spring, MD
Lucinda Buhse, FDA, CDER, OPQ, OTR, DPA, Silver Spring, MD
Brian Carlin, Consultant, Lawrenceville, NJ
Sharmista Chatterjee, FDA, CDER, OPQ, OPF, Silver Spring, MD
James Cheney, Celgene, Summit, NJ
Greg Connelly, Vertex, Boston, MA
Celia Cruz, Eli Lilly, Indianapolis, IN
Lawrence De Belder, PharmaTech, Beerse, Belgium
Ranjit Deshmukh, Ocugen
Bill Foley, Waters Corporation, Plymouth, MA
Rick Friedman, FDA, CDER, OC, OMQ, Silver Spring, MD
Neal Gallagher, Eigenvector Research, Inc., Manson, WA
Sherine George, Dow Chemical, Freeport, TX
Bo Gong, Dow Chemical, Midland, MI
Robert Guenard, Pfizer, Groton, CT
Steve Hammond, Steve Hammond Consulting
Doug Hausner, Thermo Fisher Scientific
Walter Henslee, JPAC, McDade, TX
Ernie Hillier, EJH Consulting
Kavita Ramalingam Iyer, Seagen
David Keire, FDA, CDER, OPQ, OTR, Silver Spring, MD
Mel Koch, Consultant, Seattle, WA
Evdokia Korakianiti, EMA
Theodora Kourti, Consultant
Steve Kozlowski, FDA, CDER, OPQ, OBP, Silver Spring, MD
Gulsad Kucuk, Bristol-Myers Squibb, New Brunswick, NJ
Bogdan Kurtyka, FDA, CDER, OPQ, OPF, Silver Spring, MD
Sau (Larry) Lee, FDA,CDER,OMPT,CDER,OPQ,SS, Silver Spring, MD
Lorenz Liesum, Roche, Basel, Switzerland
Matthew H. MacConnell, Air Products and Chemicals, Allentown, PA
Kevin Macias, Eli Lilly, Indianapolis, IN
Rapti Madurawe, FDA,CDER,OPQ,OPF,DPAI, Silver Spring, MD
Jose Cardoso de Menezes, IST, UTL, Lisbon, Portugal
Sarah Pope Miksinski, Gilead Sciences
Christine M. Moore, Organon, Jersey City, NJ
Antonio Moreira, University of Maryland - Baltimore County, Baltimore, MD
Moheb M. Nasr, Consultant
Thomas O'Connor, FDA, CDER, OPQ, OTR, DPQR, Silver Spring, MD
Justin Pritchard, Vertex, Boston, MA
G. K. Raju, Light Pharma, Cambridge, MA
Manoharan Ramasamy, Merck & Co., West Point, PA
Brian Rohrback, Infometrix, Inc., Bothell, WA
Sonja S. Sekulic, Pfizer, Groton, CT
Robert E. Sherman, ISA Life Fellow, Consultant, Shorewood, IL
Zhenqi (Pete) Shi, Genentech, South San Francisco, CA
Ryan Simpson, Eastman Chemical Company, Kingsport, TN
Rakhi Shah, FDA, CDER, OPQ, OPMA, Silver Spring, MD
Tim Stevens, Bristol-Myers Squibb, New Brunswick, NJ
J.D. Tate, Dow Chemical (retired), Freeport, TX
Gert Thurau, Hoffmann-LaRoche, Basel, Switzerland
Cenk Undey, Genentech, South San Francisco, CA
Juergen von Frese, Da-Sol, Utting am Ammersee, Germany
Tony Wang, Amgen, Thousand Oaks, CA
Martin Warman, Martin Warman Consultancy, Swalecliffe, UK
Xiaoyu Zhang, Eli Lilly, Indianapolis, IN
Organization Representatives
Stephen Byrn, CPPR/PTCC/CAMP, Purdue University, West Lafayette, IN
James Drennen III and Carl Anderson, DCPT, Duquesne University, Pittsburgh, PA
Brian Marquardt, University of Washington, Seattle, WA
Fernando Muzzio, Rutgers University, New Brunswick, NJ
Rodolfo Romañach, Ph.D., UPR, Mayagüez, PR,
Michael J. Tarlov, NIST, Gaithersburg, MD
Seongkyu Yoon, University of Massachusetts-Lowell, Lowell, MA